We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Microchip Technology
MCHP
$43.1B
| $34M | 0.18% |
556,629
+543,758
| +4,225% | +$35.7M |
|
127
Incyte
INCY
$24.5B
| $33.9M | 0.18% |
508,187
+221,519
| +77% | +$16.4M |
|
128
Oneok
OKE
$58.3B
| $33.6M | 0.17% |
655,628
+158,289
| +32% | +$9.41M |
|
|
PPL
129
PPL Corp
PPL
$26.7B
| $33.1M | 0.17% |
1,306,189
+49,193
| +4% | +$1.41M |
|
|
K
130
DELISTED
Kellanova
K
| $33M | 0.17% |
503,974
+26,865
| +6% | +$1.85M |
|
131
Campbell Soup
CPB
$6.74B
| $32.8M | 0.17% |
696,587
+511,673
| +277% | +$25.1M |
|
132
Manhattan Associates
MANH
$11.2B
| $32.2M | 0.17% |
242,168
+65,268
| +37% | +$8.83M |
|
133
Host Hotels & Resorts
HST
$15.6B
| $32.1M | 0.17% |
2,018,471
+1,829,699
| +969% | +$31.9M |
|
134
Knight Transportation
KNX
$11.6B
| $31.6M | 0.16% |
645,846
-24,064
| -4% | -$1.23M |
|
135
EOG Resources
EOG
$75.1B
| $31.4M | 0.16% |
281,028
+162,369
| +137% | +$18.2M |
|
136
W.R. Berkley
WRB
$25.9B
| $30.8M | 0.16% |
714,753
+185,809
| +35% | +$8.07M |
|
137
Cintas
CTAS
$81.4B
| $30.4M | 0.16% |
313,628
+293,740
| +1,477% | +$30M |
|
138
Constellation Brands
STZ
$22.9B
| $30.3M | 0.16% |
132,101
+131,175
| +14,166% | +$32M |
|
139
Mettler-Toledo International
MTD
$28.8B
| $30.3M | 0.16% |
27,925
-936
| -3% | -$1.16M |
|
140
Humana
HUM
$46.7B
| $30.1M | 0.16% |
62,110
+47,090
| +314% | +$22.9M |
|
141
Kinder Morgan
KMI
$70.7B
| $29.8M | 0.15% |
1,793,286
-16,379
| -0.9% | -$291K |
|
142
Labcorp
LH
$26.2B
| $29.7M | 0.15% |
168,664
-4,505
| -3% | -$922K |
|
143
Eagle Materials
EXP
$6.47B
| $29.6M | 0.15% |
276,544
+35,225
| +15% | +$4.22M |
|
144
Meta Platforms (Facebook)
META
$1.47T
| $28.9M | 0.15% |
212,863
-275,012
| -56% | -$44.6M |
|
145
Advanced Micro Devices
AMD
$788B
| $28.9M | 0.15% |
455,729
-353,570
| -44% | -$30.1M |
|
146
Ventas
VTR
$45.7B
| $28.6M | 0.15% |
713,217
-170,253
| -19% | -$8.37M |
|
|
SEE
147
DELISTED
Sealed Air
SEE
| $28.5M | 0.15% |
640,337
-131,592
| -17% | -$7.22M |
|
148
Regency Centers
REG
$13.9B
| $27.8M | 0.14% |
517,098
-88,264
| -15% | -$5.4M |
|
149
Dynatrace
DT
$14.3B
| $27.6M | 0.14% |
792,228
+261,025
| +49% | +$10.1M |
|
150
Exelixis
EXEL
$12.5B
| $27.4M | 0.14% |
+1,746,991
| New | +$33.8M |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.